CURE is labelled Article 9 under SFDR
Both ETFs have fees of 0.30%
KURE tracks the MSCI China All Shares Health Care 10/40 index and has a total expense ratio of 0.65%
Pfizer up as much as 15.2% on the vaccine news
Professional investors highlight which trends are for the long-term and how to find them
The coming together of regulatory developments, the rise of thematic investing and pandemic turmoil create an opportunity for impact investing thro...
